Back to GABELLI FUNDS LLC GABELLI FUNDS LLC

VIVOVIVO

Showing 0 of 17 quarters

Position history for GABELLI FUNDS LLCGABELLI FUNDS LLC's holdings in MERIDIAN BIOSCIENCE INC

As of its Q4 2022 13F, Gabelli Funds held 208,265 shares of VIVO (Meridian Bioscience), worth $6.9M. Gabelli Funds' 13F filings listed VIVO from Q1 2019 to Q4 2022, 16 quarterly filings. VIVO was 0.1% of Gabelli Funds' reported 13F portfolio.

Current Value

—

Current Shares

—

Total Value Change

$0

Total Shares Change

0

No position history available for this security.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used